Stefanie Krug PhD

Johns Hopkins University School of Medicine

Pyrazinamide inhibits the host enzyme PARP1 to reduce inflammation and accelerate bacterial clearance
Pyrazinamide inhibits the host enzyme PARP1 to reduce inflammation and accelerate bacterial clearance
Speaker
Stefanie Krug, PhD
Johns Hopkins University School of Medicine
Short Talk: Pyrazinamide Inhibits the Host Enzyme PARP1 to Reduce Inflammation and Accelerate Bacterial Clearance
Date
October 4, 2020
Speaker
Stefanie Krug, PhD
Johns Hopkins University School of Medicine
Short Talk: Pyrazinamide Inhibits the Host Enzyme PARP1 to Reduce Inflammation and Accelerate Bacterial Clearance
Date
December 4, 2020
Speaker
Stefanie Krug, PhD
Johns Hopkins University School of Medicine
Directing Discovery to Transform TB
Date
December 4, 2020
Co-Chairs
David Alland, MD
Rutgers University, New Jersey Medical School
Stefanie Krug, PhD
Johns Hopkins University School of Medicine